IM Cannabis Raises US$225,000 via Convertible Note to Fund Israeli-Focused Operations
TipRanks (Wed, 2-Sep 4:32 PM ET)
IM Cannabis closes $225K convertible note financing
Seeking Alpha News (Wed, 2-Sep 4:16 PM ET)
IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing
PRNewswire (Wed, 2-Sep 4:10 PM ET)
IM Cannabis Shares Commence Trading on 30:1 Consolidated Basis
PRNewswire (Thu, 27-Aug 4:10 PM ET)
PRNewswire (Tue, 18-Aug 5:02 PM ET)
IM Cannabis Enters into Agreement to Sell IMC Holdings and European- Focused Assets
PRNewswire (Mon, 17-Aug 6:32 AM ET)
IM Cannabis Corp. Announces Second Quarter and First Half 2026 Financial Results
PRNewswire (Thu, 13-Aug 5:04 PM ET)
IM Cannabis Raises US$250,000 of Gross Proceeds in Convertible Note Financing
PRNewswire (Fri, 7-Aug 4:02 PM ET)
IM Cannabis Provides Corporate Update
PRNewswire (Mon, 27-Jul 4:02 PM ET)
PRNewswire (Thu, 18-Jun 7:32 AM ET)
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.
Im Cannabis Corp. - Common Shares trades on the NASDAQ stock market under the symbol IMCC.
As of September 4, 2026, IMCC stock price declined to $1.98 with 76,443 million shares trading.
IMCC has a beta of 1.64, meaning it tends to be more sensitive to market movements. IMCC has a correlation of 0.03 to the broad based SPY ETF.
IMCC has a market cap of $1.20 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, IMCC traded as high as $243.00 and as low as $1.95.
IMCC has underperformed the market in the last year with a price return of -96.8% while the SPY ETF gained +19.8%. IMCC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -77.6% and -41.5%, respectively, while the SPY returned +2.0% and +0.6%, respectively.
IMCC support price is $1.98 and resistance is $2.43 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IMCC shares will trade within this expected range on the day.